CAIHL read · Jun 4, 2026
Inside the Trump-backed push to bring AI doctors into American medicine
Framework
What CAIHL does
Critical AI Health Literacy (CAIHL) is an analytical lens — Hugo Campos and Liz Salmi's 2025 National Academy of Medicine commentary, "Critical AI Health Literacy as Liberation Technology." It applies Paulo Freire's theory of critical literacy to health AI.
The central question CAIHL asks is whose interests does this AI actually serve? Four dimensions answer it: who is the primary user, where is it hosted, whose interests does it advance, and does it expand or constrain patient agency.
This deep-read separates the four dimensions on a single item from the day's scan, so you can see the specific structural shape of the AI in question — not just the bucket it landed in.
The four dimensions
How this item reads through CAIHL
Primary user
patient
Patients, families, and care partners are the primary users of this AI.
Hosting
government
Hosted or controlled by a government agency or program.
Interests
institutional
Prioritizes institutional efficiency, compliance, risk management, or revenue.
Agency
constraining
Channels patients toward predetermined pathways or substitutes for patient capabilities.
Editor's CAIHL read
One-sentence synthesis
Federal push for AI as substitute clinician. Patient is the data, the testing subject, and the casualty of governance gaps.
In the scan
How this item appeared in the daily scan
Editor's note: The case study buried in the article is the year's strongest single anecdote: 16 years of records, a different diagnosis, no clear governance for what happens next. The administration is policy-piping for tools patients are already using.
Summary: Washington Post: Administration lays groundwork for chatbots that can diagnose and prescribe; reporting includes a case where a patient's 16 years of records uploaded to ChatGPT returned a different diagnosis than their physicians had given.
methodology
Limitations
CAIHL is a lens, not a verdict. The four dimensions are conditions of use — reassess them when a tool's business model, deployment context, or patient behavior changes. See the NAM commentary for the full framework.